|
|
|
Insider
Information: |
Alton Gregg H |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
61,846 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,709,345 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
61,846 |
|
|
Total
Value |
$3,709,345 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 13 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-10-01 |
4 |
AS |
$97.09 |
$680,930 |
D/D |
(7,000) |
133,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-10-05 |
4 |
OE |
$24.30 |
$121,475 |
D/D |
5,000 |
138,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-10-05 |
4 |
AS |
$100.00 |
$500,000 |
D/D |
(5,000) |
133,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-10-26 |
4 |
AS |
$110.00 |
$550,000 |
D/D |
(5,000) |
133,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-10-26 |
4 |
OE |
$24.30 |
$121,475 |
D/D |
5,000 |
138,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-11-02 |
4 |
OE |
$24.30 |
$242,950 |
D/D |
10,000 |
143,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-11-02 |
4 |
AS |
$109.10 |
$1,312,507 |
D/D |
(12,000) |
131,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-12-01 |
4 |
AS |
$105.35 |
$1,272,159 |
D/D |
(12,000) |
129,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-12-01 |
4 |
OE |
$24.30 |
$242,950 |
D/D |
10,000 |
141,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-02-15 |
4 |
A |
$76.02 |
$18,854 |
D/D |
248 |
129,670 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
55,206 |
184,876 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-02-16 |
4 |
D |
$91.15 |
$2,988,444 |
D/D |
(32,786) |
152,090 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-03-14 |
4 |
AS |
$90.00 |
$450,000 |
D/D |
(5,000) |
147,090 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-04-01 |
4 |
S |
$91.23 |
$456,158 |
D/D |
(5,000) |
142,090 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-04-19 |
4 |
AS |
$100.00 |
$4,000,574 |
D/D |
(40,000) |
137,964 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-04-19 |
4 |
OE |
$26.99 |
$968,239 |
D/D |
35,874 |
177,964 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2016-09-22 |
4 |
AS |
$81.84 |
$409,220 |
D/D |
(5,000) |
132,964 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2016-11-09 |
4 |
AS |
$79.00 |
$790,000 |
D/D |
(10,000) |
122,964 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
123,279 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,716 |
130,995 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-02-16 |
4 |
D |
$70.31 |
$462,429 |
D/D |
(6,577) |
124,418 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,430 |
122,988 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-03-30 |
4 |
S |
$67.48 |
$337,392 |
D/D |
(5,000) |
117,988 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-05-01 |
4 |
AS |
$68.31 |
$341,529 |
D/D |
(5,000) |
112,988 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-06-01 |
4 |
AS |
$65.02 |
$325,114 |
D/D |
(5,000) |
107,988 |
0 |
- |
|
360 Records found
|
|
Page 13 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|